News | June 23, 2009

ThromCat XT Thrombectomy Catheter System Receives CE Mark

June 23, 2009 - Kensey Nash Corp. today said the ThromCat XT Thrombectomy Catheter System was granted CE marking approval, allowing for the sale of the product throughout the European Economic Area (EEA).

The ThromCat XT System, a mechanical thrombectomy catheter designed to remove thrombus from a patient, is indicated for use in both the coronary and peripheral vasculature. The CE mark approval meets the criteria established for a milestone payment of $1.5 million under the company's development and regulatory services agreement with The Spectranetics Corp. The milestone payment to Kensey Nash will be recorded as deferred revenue and will be recognized into revenue over the remaining period of the agreement.

The ThromCat XT System is based upon the same design principles as the original ThromCat product, which utilizes a high-speed rotary helix within a flexible atraumatic 7 Fr. extraction catheter to safely and effectively remove thrombus. The ThromCat XT extends the capability of this innovative first generation disposable device by incorporating an advanced extraction helix technology that improves the product's performance, particularly when used in more advanced thrombus. The ease-of-use of the ThromCat XT System is enhanced by further simplifying the setup procedure of the original device, resulting in an even shorter set up time. In addition, the device incorporates a new catheter jacket technology to allow use in more challenging anatomy, thereby extending the utility of this powerful and disposable device, the company said.

For more information: www.kenseynash.com

Related Content

global thrombectomy devices market, Allied Market Research report, 2022
News | Thrombectomy Devices| January 05, 2017
January 5, 2017 — A new report published by Allied Market Research forecasts that the global...
Neuravi, EmboTrap II stent retriever, thrombectomy device, acute stroke, European launch, CE Mark
News | Thrombectomy Devices| September 28, 2016
Neuravi recently announced Conformité Européenne (CE) Mark approval and launch of the company’s newly available...
Penumbra System, ACE68 Reperfusion Catheter, thrombectomy device, SNIS 2016, acute ischemic stroke patients
Technology | Thrombectomy Devices| July 27, 2016
July 27, 2016 — Penumbra Inc. announced U.S.
Boston Scientific, Fetch 2 aspiration catheter, Class 1 recall
News | Thrombectomy Devices| April 20, 2016
April 20, 2016 — Boston Scientific Corp. announced a U.S.
SITS Open trial, mechanical thrombectomy devices. pREset, stroke treatment
News | Thrombectomy Devices| March 08, 2016
March 8, 2016 — phenox GmbH announced participation in the SITS Open clinical trial, where pREset and pREset LITE ...
thrombus aspiration, STEMI patients, TCT 2015, TOTAL study
Feature | Thrombectomy Devices| October 20, 2015
A pair of studies presented at the 27th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium...
acute ischemic stroke, larger thrombi retrieval, improved neurological recovery, ESC 2015, MR CLEAN trial, sub-study
Feature | Thrombectomy Devices| September 02, 2015
Retrieval of larger thrombi during intra-arterial treatment (IAT) is associated with improved neurological recovery...
STEMI, ultrasound to treat heart attacks, ultrasound to treat STEMI
Feature | Thrombectomy Devices| June 12, 2015
Breakthrough Research Demonstrates Contrast Ultrasound Can be Used as Heart Attack Treatment 
Aspire, thrombectomy, C. Dorn Smith, aspirators, clot, cold leg, removal

Clot in femoral artery caused by atrial fibrillation

News | Thrombectomy Devices| June 11, 2015
C. Dorn Smith, M.D., vascular surgeon in Kingstree, South Carolina, was successful in using a new device to remove...
Overlay Init